BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6779622)

  • 1. IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.
    Zarrabi MH; Stark RS; Kane P; Dannaher CL; Chandor S
    Am J Clin Pathol; 1981 Jan; 75(1):1-10. PubMed ID: 6779622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM myeloma--its distinction from Waldenström's macroglobulinemia.
    Takahashi K; Yamamura F; Motoyama H
    Acta Pathol Jpn; 1986 Oct; 36(10):1553-63. PubMed ID: 3099541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgM myeloma: 6 cases and a review of the literature].
    De Gramont A; Grosbois B; Michaux JL; Peny AM; Pollet JP; Smadja N; Krulik M; Debray J; Bernard JF; Monconduit M
    Rev Med Interne; 1990; 11(1):13-8. PubMed ID: 2109345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM Myeloma: An IgM Gammopathy Distinct from Waldenstrom's Macroglobulinemia.
    Nordquist LT; Saba HI; Moscinski LC
    Hematology; 2001; 6(1):53-8. PubMed ID: 27419604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
    Wang E; Kulbacki E; Stoecker M
    Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM multiple myeloma: report of four cases and review of the literature.
    Annibali O; Petrucci MT; Del Bianco P; Gallucci C; Levi A; Foà R; Avvisati G
    Leuk Lymphoma; 2006 Aug; 47(8):1565-9. PubMed ID: 16966268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM myeloma: a report of four cases.
    Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
    Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A descriptive study of plasma cell dyscrasias in Egyptian population.
    Kassem NM; El Zawam H; Kassem HA; El Nahas T; El Husseiny NM; El Azeeim HA
    J Egypt Natl Canc Inst; 2014 Jun; 26(2):67-71. PubMed ID: 24841156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
    Chehal A; Taher A; Shamseddine A
    Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral nerve damage during multiple myeloma and Waldenstrom's macroglobulinemia: an ultrastructural and immunopathologic study.
    Vital C; Vallat JM; Deminiere C; Loubet A; Leboutet MJ
    Cancer; 1982 Oct; 50(8):1491-7. PubMed ID: 6288215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient.
    Fine JM; Gorin NC; Gendre JP; Petitpierre JC; Labro-Bryskier MT; Lambin P
    Acta Med Scand; 1981; 209(3):229-34. PubMed ID: 6784449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal clues apparently distinguishing Waldenstrom's macroglobulinemia from multiple myeloma and leukemia.
    Rothschild BM; Ruhli F; Rothschild C
    Am J Hum Biol; 2002; 14(4):532-7. PubMed ID: 12112574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
    Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
    Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
    Kyle RA; Ansell SM; Kapoor P
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgA.
    Tursz T; Brouet JC; Flandrin G; Danon F; Clauvel JP; Seligmann M
    Am J Med; 1977 Oct; 63(4):499-502. PubMed ID: 410294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cast nephropathy in a case of Waldenström's macroglobulinemia.
    Isaac J; Herrera GA
    Nephron; 2002 Jul; 91(3):512-5. PubMed ID: 12119489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.
    Karlsson J; Roalfe L; Hogevik H; Zancolli M; Andréasson B; Goldblatt D; Wennerås C
    Clin Vaccine Immunol; 2016 Apr; 23(4):379-85. PubMed ID: 26912783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.